Royal Bank Of Canada Beam Therapeutics Inc. Transaction History

Royal Bank Of Canada

$471 Billion
Q3 2024

A detailed history of Royal Bank Of Canada transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 8,682 shares of BEAM stock, worth $219,567. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,682

Previous 8,614 0.79%

Holding current value

$219,567

Previous $201,000 5.47%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$22.57 - $33.14 $1,534 - $2,253	68 Added 0.79%	8,682 $212,000
Q2 2024 Aug 14, 2024	BUY	$21.22 - $32.66 $96,402 - $148,374	4,543 Added 111.59%	8,614 $201,000
Q1 2024 Nov 05, 2024	SELL	$23.46 - $45.07 $106,578 - $204,753	-4,543 Reduced 52.74%	4,071 $134,000
Q1 2024 May 15, 2024	BUY	$23.46 - $45.07 $50,087 - $96,224	2,135 Added 110.28%	4,071 $134,000
Q4 2023 Feb 14, 2024	SELL	$17.69 - $30.76 $2,494 - $4,337	-141 Reduced 6.79%	1,936 $52,000
Q3 2023 Nov 14, 2023	SELL	$23.01 - $32.46 $489,192 - $690,099	-21,260 Reduced 91.1%	2,077 $49,000
Q2 2023 Aug 14, 2023	BUY	$29.32 - $35.99 $41,282 - $50,673	1,408 Added 6.42%	23,337 $745,000
Q1 2023 May 15, 2023	SELL	$30.15 - $48.79 $98,349 - $159,152	-3,262 Reduced 12.95%	21,929 $671,000
Q4 2022 Feb 14, 2023	BUY	$36.73 - $51.6 $22,588 - $31,734	615 Added 2.5%	25,191 $985,000
Q3 2022 Nov 14, 2022	SELL	$39.79 - $70.31 $274,590 - $485,209	-6,901 Reduced 21.92%	24,576 $1.17 Million
Q2 2022 Aug 15, 2022	BUY	$29.86 - $62.36 $349,093 - $729,050	11,691 Added 59.09%	31,477 $1.22 Million
Q1 2022 May 16, 2022	BUY	$53.73 - $82.16 $733,414 - $1.12 Million	13,650 Added 222.46%	19,786 $1.13 Million
Q4 2021 Feb 14, 2022	BUY	$68.02 - $99.06 $290,853 - $423,580	4,276 Added 229.89%	6,136 $489,000
Q3 2021 Nov 15, 2021	SELL	$84.37 - $133.6 $240,285 - $380,492	-2,848 Reduced 60.49%	1,860 $162,000
Q2 2021 Aug 16, 2021	BUY	$64.12 - $128.71 $301,876 - $605,966	4,708 New	4,708 $605,000

Others Institutions Holding BEAM

# of Institutions

236

Shares Held

75.2M

Call Options Held

438K

Put Options Held

232K

View Full List

About Beam Therapeutics Inc.

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $1.78B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

More about BEAM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Beam Therapeutics Inc. Transaction History